Whalesbook
Turtlemint, jo ek Indian insurtech company hai, investors se milne pahunch gayi hai. Plan hai ₹2,000 Crore ka IPO lane ka. Security and Exchange Board of India (SEBI) mein 45 din ke andar updated DRHP-II file karne wale hain. Lagta hai listing aur paisa raise karne ke liye ready hain.
Inka target valuation toh $1.3 Billion se $1.5 Billion tak hai, jo ki 2022 ke $900 million se kaafi zyada hai. Iss IPO mein ₹660 Crore ka fresh issue aur ₹1,340 Crore ka offer for sale hoga, jisse Nexus Venture Partners aur Peak XV Partners jaise existing investors ko liquidity milegi. Lekin situation thodi complicated hai, kyunki H1 FY26 mein company ka net loss 26% badh kar ₹125 crore ho gaya hai. Iska reason hai partner acquire karne aur unhe maintain karne mein laga bahut sara paisa, jo expenses ka 76% se zyada hai. Aur revenue toh lagbhag poora (98.9%) commission se hi aata hai.
India ka digital insurance market future mein kaafi bada hone wala hai, lagbhag ₹5.3-5.8 trillion tak FY30 tak. Yahan Turtlemint ka competition PB Fintech jaise players se hai, jo already list ho chuka hai. Par sabse bada tension hai 'Bima Sugam' ka, jo IRDAI ka naya platform hai insurance process ko easy banane ke liye. Bima Sugam se intermediary commissions kam ho sakte hain aur distribution model change ho sakta hai. Reports aa rahi hain ki insurers Bima Sugam par zero-commission products bhi de sakte hain, jo Turtlemint ke business model ke liye seedha challenge hai.
Aajkal India mein IPO market mein companies ko growth se zyada profitability par focus karna pad raha hai. Recent startup IPOs mein 55% apne issue price se neeche trade kar rahe hain. Investors ab sustainable profit dekhna chahte hain. Hallanki, Turtlemint ne FY24 mein chota profit dikhaya tha, par H1 FY26 mein badhte losses IPO ke liye mushkil khadi kar sakte hain. Wahi, company 'Beyond Top 30' (B30+) markets mein focus kar rahi hai, jahan se future growth ki ummeed hai.
Toh risk ye hai ki business model poora commission par depend karta hai (98.9% revenue). Aur Bima Sugam, jise 'UPI for insurance' kaha ja raha hai, vo seedha commissions ko target karega. Jab insurers khud Bima Sugam par zero-commission products la rahe hain, toh Turtlemint ka business model atak sakta hai. Upar se operational costs (partner acquisition mein 76%+) badh rahe hain. Yeh sab milakar IPO valuation risky lag sakta hai, jab market profitable companies ko zyada prefer kar raha hai.
India ka insurance distribution market badhne wala hai aur B30+ markets par Turtlemint ka focus sahi direction mein hai. Par IPO success aur investor ka confidence tabhi badhega jab Turtlemint dikhaye ki vo revenue risks kaise kam karega aur sustainable profit kaise layega. Ab sirf growth stories nahi, operational efficiency aur solid financial model chalega.